AMA Ed Hub Logo

Learn more on naloxone from AMA Ed Hub™
Red JAMA Logo

Learn more on naloxone from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on naloxone from PolicyFinder
Poster for naloxone

How to administer Naloxone

2 Min Read
Clear Search
·
2 Min Read

AMA applauds FDA's approval of second OTC naloxone product

The AMA has long advocated for improved access to OTC naloxone as the deadly drug overdose epidemic continues to devastate communities.

Press Releases
2023 Annual Meeting delegates from Kansas and Missouri
·
4 Min Read

Put naloxone in schools so it can save lives

Opioid overdose-reversing drugs such as naloxone save lives. They should be available in educational settings and public areas, the AMA says.

Behavioral Health
Narcan nasal spray
·
4 Min Read

Narcan lands OTC approval: What it means for patients, doctors

The drug’s manufacturer and retailers must help ensure the lifesaving opioid overdose-reversal medication is widely available at an affordable price. 

Behavioral Health
·
11 Min Read

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

series
Behavioral Health
AMA Update
·
11 Min Read

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

series
Behavioral Health
AMA Update Podcast
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of March 27, 2023

In the news: FDA rule on salt substitutes, undiagnosed atrial fibrillation in the U.S., Narcan (naloxone) to be available over the counter and more.

Publications & Newsletters
·
2 Min Read

AMA statement on making naloxone available over the counter

The AMA strongly supports the FDA decision to make the opioid overdose-reversing drug naloxone available over the counter, a position we have long championed.

Press Releases
·
13 Min Read

Feb. 24, 2023: National Advocacy Update

FDA advisory panels vote 19-0 in favor of OTC naloxone and more in the latest National Advocacy Update.

Advocacy Update
·
2 Min Read

AMA: FDA panels’ naloxone recommendation will save lives

Two advisory committees voted today to recommend to the FDA that naloxone, the overdose-reversing drug, be available over the counter.

Press Releases